Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun:156:104808.
doi: 10.1016/j.phrs.2020.104808. Epub 2020 Apr 10.

Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19)

Farshad Abedi  1 , Ramin Rezaee  2 , Gholamreza Karimi  3
Affiliations

Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19)

Farshad Abedi et al. Pharmacol Res. 2020 Jun.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Positive role of Rho kinase inhibitors in pulmonary endothelial cells infected with SARS-CoV-2.
See this image and copyright information in PMC

References

    1. Lai C.-C., Shih T.-P., Ko W.-C., Tang H.-J., Hsueh P.-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. International journal of antimicrobial agents. 2020 - PMC - PubMed
    1. Groneberg D.A., Hilgenfeld R., Zabel P. Molecular mechanisms of severe acute respiratory syndrome (SARS) Respiratory Research. 2005;6(1):8. - PMC - PubMed
    1. Abedi F., Hayes A.W., Reiter R., Karimi G. Acute Lung Injury: the therapeutic role of Rho kinase inhibitors. Pharmacological Research. 2020 - PubMed
    1. Cao Y., Li L., Feng Z., Wan S., Huang P., Sun X., Wen F., Huang X., Ning G., Wang W. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discovery. 2020;6(1):1–4. - PMC - PubMed
    1. Zhang H., Penninger J.M., Li Y., Zhong N., Slutsky A.S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine. 2020:1–5. - PMC - PubMed

Substances